82 related articles for article (PubMed ID: 19150524)
1. What will it take to obtain DNA methylation markers for early cervical cancer detection?
Nephew KP
Gynecol Oncol; 2009 Feb; 112(2):291-2. PubMed ID: 19150524
[No Abstract] [Full Text] [Related]
2. Understanding the mechanisms of FHIT inactivation in cervical cancer for biomarker development.
Lea JS; Ashfaq R; Muneer S; Burbee DG; Miller DS; Minna JD; Muller CY
J Soc Gynecol Investig; 2004 Jul; 11(5):329-37. PubMed ID: 15219888
[TBL] [Abstract][Full Text] [Related]
3. Emerging technology in cervical cancer screening: status of molecular markers.
Padilla-Paz LA
Clin Obstet Gynecol; 2005 Mar; 48(1):218-25. PubMed ID: 15725874
[No Abstract] [Full Text] [Related]
4. Can DNA methylation tests improve the accuracy of cervical screening?
Bowden SJ; Lathouras K; Kyrgiou M
BJOG; 2021 Feb; 128(3):515. PubMed ID: 32762096
[No Abstract] [Full Text] [Related]
5. The role of ADCYAP1, adenylate cyclase activating polypeptide 1, as a methylation biomarker for the early detection of cervical cancer.
Jung S; Yi L; Jeong D; Kim J; An S; Oh TJ; Kim CH; Kim CJ; Yang Y; Kim KI; Lim JS; Lee MS
Oncol Rep; 2011 Jan; 25(1):245-52. PubMed ID: 21109983
[TBL] [Abstract][Full Text] [Related]
6. Promoter methylation of SEPT9 as a potential biomarker for early detection of cervical cancer and its overexpression predicts radioresistance.
Jiao X; Zhang S; Jiao J; Zhang T; Qu W; Muloye GM; Kong B; Zhang Q; Cui B
Clin Epigenetics; 2019 Aug; 11(1):120. PubMed ID: 31426855
[TBL] [Abstract][Full Text] [Related]
7. The feasibility of detecting endometrial and ovarian cancer using DNA methylation biomarkers in cervical scrapings.
Chang CC; Wang HC; Liao YP; Chen YC; Weng YC; Yu MH; Lai HC
J Gynecol Oncol; 2018 Jan; 29(1):e17. PubMed ID: 29185275
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation markers as triage test for the early identification of cervical lesions in a Chinese population.
Li N; Hu Y; Zhang X; Liu Y; He Y; van der Zee AGJ; Schuuring E; Wisman GBA
Int J Cancer; 2021 Apr; 148(7):1768-1777. PubMed ID: 33300604
[TBL] [Abstract][Full Text] [Related]
9. [Epigenetic alterations in cervical cancer progression].
Ríos-Romero M; Soto-Valladares AG; Piña-Sánchez P
Rev Med Inst Mex Seguro Soc; 2015; 53 Suppl 2():S212-7. PubMed ID: 26462519
[TBL] [Abstract][Full Text] [Related]
10. Biological implications and therapeutic significance of DNA methylation regulated genes in cervical cancer.
Bhat S; Kabekkodu SP; Noronha A; Satyamoorthy K
Biochimie; 2016 Feb; 121():298-311. PubMed ID: 26743075
[TBL] [Abstract][Full Text] [Related]
11. Global methylation silencing of clustered proto-cadherin genes in cervical cancer: serving as diagnostic markers comparable to HPV.
Wang KH; Lin CJ; Liu CJ; Liu DW; Huang RL; Ding DC; Weng CF; Chu TY
Cancer Med; 2015 Jan; 4(1):43-55. PubMed ID: 25418975
[TBL] [Abstract][Full Text] [Related]
12. Methylomics analysis identifies epigenetically silenced genes and implies an activation of β-catenin signaling in cervical cancer.
Chen YC; Huang RL; Huang YK; Liao YP; Su PH; Wang HC; Chang CC; Lin YW; Yu MH; Chu TY; Lai HC
Int J Cancer; 2014 Jul; 135(1):117-27. PubMed ID: 24310984
[TBL] [Abstract][Full Text] [Related]
13. Identification and Validation of a 3-Gene Methylation Classifier for HPV-Based Cervical Screening on Self-Samples.
Verlaat W; Snoek BC; Heideman DAM; Wilting SM; Snijders PJF; Novianti PW; van Splunter AP; Peeters CFW; van Trommel NE; Massuger LFAG; Bekkers RLM; Melchers WJG; van Kemenade FJ; Berkhof J; van de Wiel MA; Meijer CJLM; Steenbergen RDM
Clin Cancer Res; 2018 Jul; 24(14):3456-3464. PubMed ID: 29632006
[No Abstract] [Full Text] [Related]
14. Performance of a DNA methylation marker panel using liquid-based cervical scrapes to detect cervical cancer and its precancerous stages.
Schmitz M; Eichelkraut K; Schmidt D; Zeiser I; Hilal Z; Tettenborn Z; Hansel A; Ikenberg H
BMC Cancer; 2018 Dec; 18(1):1197. PubMed ID: 30509219
[TBL] [Abstract][Full Text] [Related]
15. Aberrant gene-specific DNA methylation signature analysis in cervical cancer.
Bhat S; Kabekkodu SP; Varghese VK; Chakrabarty S; Mallya SP; Rotti H; Pandey D; Kushtagi P; Satyamoorthy K
Tumour Biol; 2017 Mar; 39(3):1010428317694573. PubMed ID: 28351298
[TBL] [Abstract][Full Text] [Related]
16. CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patients.
Widschwendter A; Ivarsson L; Blassnig A; Müller HM; Fiegl H; Wiedemair A; Müller-Holzner E; Goebel G; Marth C; Widschwendter M
Int J Cancer; 2004 Mar; 109(2):163-6. PubMed ID: 14750164
[TBL] [Abstract][Full Text] [Related]
17. Combined clinical and genetic testing algorithm for cervical cancer diagnosis.
Liou YL; Zhang TL; Yan T; Yeh CT; Kang YN; Cao L; Wu N; Chang CF; Wang HJ; Yen C; Chu TY; Zhang Y; Zhang Y; Zhou H
Clin Epigenetics; 2016; 8():66. PubMed ID: 27293491
[TBL] [Abstract][Full Text] [Related]
18. Putative biomarkers for cervical cancer: SNVs, methylation and expression profiles.
Cardoso MFS; Castelletti CHM; Lima-Filho JL; Martins DBG; Teixeira JAC
Mutat Res Rev Mutat Res; 2017 Jul; 773():161-173. PubMed ID: 28927526
[TBL] [Abstract][Full Text] [Related]
19. Quantitative methylation analysis of human papillomavirus 16L1 gene reveals potential biomarker for cervical cancer progression.
Chaiwongkot A; Niruthisard S; Kitkumthorn N; Bhattarakosol P
Diagn Microbiol Infect Dis; 2017 Dec; 89(4):265-270. PubMed ID: 28985972
[TBL] [Abstract][Full Text] [Related]
20. DNA ploidy cytometry testing for cervical cancer screening in China - letter.
Garner DM; Guillaud MD; MacAulay CE
Clin Cancer Res; 2010 Jul; 16(13):3517. PubMed ID: 20570931
[No Abstract] [Full Text] [Related]
[Next] [New Search]
